These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 12671973)
1. Antibody-catalyzed enantioselective Norrish type II cyclization. Saphier S; Sinha SC; Keinan E Angew Chem Int Ed Engl; 2003 Mar; 42(12):1378-81. PubMed ID: 12671973 [No Abstract] [Full Text] [Related]
2. Origin of selectivity in the antibody 20F10-catalyzed Yang cyclization. Saphier S; Hu Y; Sinha SC; Houk KN; Keinan E J Am Chem Soc; 2005 Jan; 127(1):132-45. PubMed ID: 15631463 [TBL] [Abstract][Full Text] [Related]
3. A catalytic antibody against a tocopherol cyclase inhibitor. Manetsch R; Zheng L; Reymond MT; Woggon WD; Reymond JL Chemistry; 2004 May; 10(10):2487-506. PubMed ID: 15146522 [TBL] [Abstract][Full Text] [Related]
4. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog. Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011 [TBL] [Abstract][Full Text] [Related]
6. Antibody catalysis of a reaction otherwise strongly disfavoured in water. Shabat D; Itzhaky H; Reymond JL; Keinan E Nature; 1995 Mar; 374(6518):143-6. PubMed ID: 7877686 [TBL] [Abstract][Full Text] [Related]
7. Structural basis for antibody catalysis of a disfavored ring closure reaction. Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817 [TBL] [Abstract][Full Text] [Related]
8. Origins and predictions of stereoselective antibody catalysis: theoretical analysis of Diels-Alder catalysis by 39A11 and its germ-line antibody. Zhang X; Deng Q; Yoo SH; Houk KN J Org Chem; 2002 Dec; 67(25):9043-53. PubMed ID: 12467427 [TBL] [Abstract][Full Text] [Related]
9. Experimental determination of the absolute enantioselectivity of an antibody-catalyzed Diels-Alder reaction and theoretical explorations of the origins of stereoselectivity. Cannizzaro CE; Ashley JA; Janda KD; Houk KN J Am Chem Soc; 2003 Mar; 125(9):2489-506. PubMed ID: 12603137 [TBL] [Abstract][Full Text] [Related]
11. Catalytic enantioselective radical cyclization via regiodivergent epoxide opening. Gansäuer A; Shi L; Otte M J Am Chem Soc; 2010 Sep; 132(34):11858-9. PubMed ID: 20687604 [TBL] [Abstract][Full Text] [Related]
12. Hapten design for the generation of catalytic antibodies. Thomas NR Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348 [TBL] [Abstract][Full Text] [Related]
13. Optimization of the modification of carrier proteins with aminated haptens. Fuentes M; Palomo JM; Mateo C; Venteo A; Sanz A; Fernández-Lafuente R; Guisan JM J Immunol Methods; 2005 Dec; 307(1-2):144-9. PubMed ID: 16263130 [TBL] [Abstract][Full Text] [Related]
14. Tech.Sight. Antibody design by man and nature. Wentworth P Science; 2002 Jun; 296(5576):2247-9. PubMed ID: 12077422 [TBL] [Abstract][Full Text] [Related]
15. Catalytic antibodies: evolution of protein function in real time. Lerner RA; Janda KD EXS; 1995; 73():121-38. PubMed ID: 7579971 [TBL] [Abstract][Full Text] [Related]
16. An organophosphorus hapten used in the preparation of monoclonal antibody and as an active immunization vaccine in the detoxication of soman poisoning. Jia P; Wang Y; Yu M; Wu J; Yang R; Zhao Y; Zhou L Toxicol Lett; 2009 May; 187(1):45-51. PubMed ID: 19429243 [TBL] [Abstract][Full Text] [Related]